S. Karger AG

SHERPA: Unknown

People

  1. Levine
    Levine
  2. Koche
    Koche
  3. Rudin
    Rudin
  4. Scheinberg
    Scheinberg
  5. Yang
    Yang
  6. Cheung
    Cheung
  7. Clarkson
    Clarkson
  8. Correa
    Correa
  9. Gutin
    Gutin
  10. Kushner
    Kushner

Groups

  1. Center for Molecular Imaging and Biotechnology (12)
  2. GSK Faculty (12)
  3. Department of Medicine (10)
  4. Adult Leukemia (8)
  5. Center for Hematologic Malignancies (8)
  6. Hematologic Malignancies, Division of (8)
  7. Executive Committee, Center for Hematologic Malignancies (6)
  8. Human Oncology and Pathogenesis Program (6)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (5)
  10. Tow Center for Developmental Oncology (TCDO) (4)
Search Within
  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Meeting Abstract (9)
  2. Journal Article (3)
Groups
  1. Center for Molecular Imaging and Biotechnology (12)
  2. GSK Faculty (12)
  3. Department of Medicine (10)
  4. Adult Leukemia (8)
  5. Center for Hematologic Malignancies (8)
  6. Hematologic Malignancies, Division of (8)

More Groups

People
  1. Ross Levine (6)
  2. Charles Rudin (2)
  3. David Scheinberg (2)
  4. Li Yang (2)
  5. Richard Koche (2)
  6. Bayard Clarkson (1)

More People

Years
  1. 2023 (1)
  2. 2022 (3)
  3. 2020 (3)
  4. 2013 (1)
  5. 2008 (1)
  6. 1999 (1)

More Years

Publications
  1. Oncology Research and Treatment (7)
  2. Acta Haematologica (2)
  3. Hormone Research (1)
  4. Onkologie (1)
  5. Stereotactic and Functional Neurosurgery (1)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neopeptide diversity and similarity to the unmutated immunopeptidome is associated with response to immune checkpoint blockade therapy
    Meeting Abstract

    Klatt, M.; Molvi, Z.; Panageas, K.; Wells, D.; Hellmann, M.; Merghoub, T.; Wolchok, J.; O'Reilly, R.; Keller, U.; Scheinberg, D.
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • Durvalumab (D) + platinum-etoposide (EP) in 1L extensivestage small-cell lung cancer (ES-SCLC): Exploratory analysis of SCLC molecular subtypes in CASPIAN
    Meeting Abstract

    Xie, M.; Chugh, P.; Broadhurst, H.; Lai, Z.; Whitston, D.; Paz-Ares, L.; Gay, C.; Byers, L.; Rudin, C. M.; Stewart, R.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • Resistenz auf typ II JAK2 inhibition via persistente MAPK aktivierung kann durch MEK inhibition überwunden werden
    Meeting Abstract

    Codilupi, T.; Szybinski, J.; Brkic, S.; Stivala, S.; Yang, J. L.; Wicki, A.; Ghosh, N.; Passweg, J.; Dirnhofer, S.; Levine, R. L.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • 1L durvalumab (D) + platin-etoposid (EP) beim fortgeschrittenen kleinzelligen lungenkarzinom (ES-SCLC): Explorative analyse der molekularen SCLC-subtypen in der caspian-studie
    Meeting Abstract

    Schulz, C.; Xie, M.; Chugh, P.; Broadhurst, H.; Lai, Z.; Whitston, D.; Paz-Ares, L.; Gay, C.; Byers, L.; Rudin, C. M.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • Combined JAK2 and ERK1/2 kinase inhibition as a novel therapeutic approach in myeloproliferative neoplasms
    Meeting Abstract

    Brkic, S.; Stivala, S.; Santopolo, A.; Jungius, S.; Passweg, J. R.; Tsakiris, D.; Dirnhofer, S.; Levine, R. L.; Meyer, S. C.
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Resistance to type II JAK2 inhibition in MPN is dependent on MEK-ERK activation and is targetable
    Meeting Abstract

    Codilupi, T.; Szybinski, J.; Wicki, A.; Yang, J. L.; Ghosh, N.; Passweg, J.; Tsakiris, D.; Levine, R. L.; Koche, R.; Meyer, S. C.
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • Dual genetic targeting of ERK1 and ERK2 abrogates the competitive potential of the myeloproliferative neoplasm clone
    Meeting Abstract

    Stivala, S.; Brkic, S.; Santopolo, A.; Dirnhofer, S.; Passweg, J.; Tsakiris, D.; Neel, B.; Levine, R.; Meyer, S.
    Oncology Research and Treatment (2020)

    Fulltext@MSK | Save
  • DNA cytosine methylation during in vivo commitment of human hematopoietic stem cells from healthy individuals, and implications for acute myeloid leukemia
    Meeting Abstract

    Christopeit, M.; Bartholdy, B.; Will, B.; Mo, Y.; Barreyro, L.; Yu, Y.; Bhagat, T. D.; Okoye-Okafor, U. C.; Todorova, T. I.; Greally, J. M.; more...
    Onkologie (2013)

    Fulltext@MSK | Save
  • JAK2 and MPL mutations in myeloproliferative neoplasms
    Journal Article

    Koppikar, P.; Levine, R. L.
    Acta Haematologica (2008)

    Fulltext@MSK | Save
  • Concordance between functional magnetic resonance imaging and intraoperative language mapping
    Journal Article

    Ruge, M. I.; Victor, J.; Hosain, S.; Correa, D. D.; Relkin, N. R.; Tabar, V.; Brennan, C.; Gutin, P. H.; Hirsch, J.
    Stereotactic and Functional Neurosurgery (1999)

    Fulltext@MSK | Save